Stay updated on GENEr8-AAV5+ in Severe Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the GENEr8-AAV5+ in Severe Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GENEr8-AAV5+ in Severe Hemophilia A Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page presents the ClinicalTrials.gov record for a BioMarin gene therapy study in severe hemophilia A, including its terminated status and results-related details. It also provides eligibility criteria, study locations, measured outcomes, and protocol documents.
    Difference
    49%
    Check dated 2026-11-08T10:19:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T11:33:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-25T11:44:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:34:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-11T14:30:19.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual study content. The additions display a minimal header with '403' and a 'Home' link, signaling an access restriction rather than updated study information.
    Difference
    17%
    Check dated 2026-09-20T04:34:42.000Z thumbnail image

Stay in the know with updates to GENEr8-AAV5+ in Severe Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GENEr8-AAV5+ in Severe Hemophilia A Clinical Trial page.